News
KALA Bio completes enrollment in CHASE trial, advancing KPI-012 for treating persistent corneal epithelial defects. Topline ...
5h
The Healthy @Reader's Digest on MSNFDA: Boar’s Head Deli Brand Has Initiated Another Grocery Recall, This Time Affecting One StateExactly a year after the brand's historically large lunch meat recall comes a report about an issue with another mainstream product.
Utah dentists call on public to submit comments to FDA in support of ingestible fluoride supplements
Fluoride has been shown scientifically for decades to be the best way at combatting tooth decay, and if we pull that away, we ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
Georgia's congressional delegation is advocating for FDA reconsideration of the drug elamipretide for Hope Filchak.
The FDA recalled some chocolate products by the Weaver Nut Company chocolate, warning about possible serious to ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care The Big Story Senate panel clears ...
Lawmakers are making slow headway on assembling a fiscal year 2026 package of 12 annual funding bills that provide money for ...
It’s frightening,” said Committee Chair JoCasta Zamarripa during a May 20 renewal hearing for Rama Foods, where the THC ...
Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.
Ultragenyx Pharmaceutical said federal regulators have issued a complete response letter to its application for a metabolic disorder treatment that may delay the potential approval to 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results